Tuesday, April 14, 2020 Daily Archives

Patient Access Tops the List of Advanced Therapy Milestones at Phacilitate 2020

In a highly anticipated presentation at the 2020 Phacilitate Leaders World event — part of Advanced Therapies Week, along with the World Stem Cell Summit in Miami, FL — Susan Nichols (chief executive officer for Falcon Therapeutics), highlighted 10 events from 2019 that drove conversation, investment, and innovation in regenerative medicine. Although clustered regularly interspaced short palindromic repeats (CRISPR), business consolidations, and production capacity powered the cell and gene therapy (CGT) space in 2019, a new proactive focus on patient…

Discussions at Phacilitate 2020 on Business, Manufacturing, and Future Trends

Presenters in the three main program tracks at the Phacilitate Leaders World conference in Miami, FL, this past January represented sponsor-developers of cell/gene-therapy (CGT) products, contract service providers, and technology suppliers to the industry. Topics include process and product development strategies for advanced therapies, regulatory and inspector expectations, automation and closed-system processing, the choice between in-house and outsourced manufacturing, quality assurance and control, analytical methods, viral vectors, and artificial intelligence and Industry 4.0. At the end of each session, presenters…

The Technology of Tomorrow — Today

Sponsored by BioProcess International and its sister publication BioProcess Insider, the “Tech of Tomorrow Zone” at Phacilitate 2020 played host to a number of companies showcasing platforms and ideas that they believe can revolutionize cell and gene therapy (CGT) manufacturing. Some common themes arose in this diverse zone, highlighting technologies from stem-cell supply solutions to viral-vector filling. Participating companies are aware of the complexities involved in producing regenerative medicines, and each proposed solution was intended to reduce the burden on…

No official cases but North Korea looks to up coronavirus testing

North Korea has asked for help to increase COVID-19 monitoring capacity and has received reagents needed for testing, according to the WHO. Officially no COVID-19 cases have been reported in North Korea (DPRK). However, only a few hundred people have been tested for SARS-CoV2, the virus that causes the disease, according to World Health Organization (WHO) representative to DPR Korea, Edwin Salvador. “The WHO has been receiving weekly updates from the [DPRK] Ministry of Health on COVID-19. As of 2…